v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
3 Months Ended 161 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
OPERATING ACTIVITIES      
Net loss $ (803,265) $ (1,965,771) $ (38,335,329)
Depreciation     52,694
Gain on disposal of equipment     36,623
Stock-based compensation-product development costs     528,618
Stock-based compensation-interest expenses 231,948 1,493,702 8,185,025
Stock-based compensation-selling, general and administration     3,223,816
Stock-based compensation-professional fees   43,936 44,815
Other non-cash items included in net loss     294,020
Non-cash imputed interest expenses 41,797 44,699 3,039,625
Unpaid Interest expense on line of credit 82,142   297,695
Equity instruments issued to settle liabilities     1,871,718
Changes in operating assets and liabilities:      
Decrease in receivables     8,725
(Increase) decrease in prepaid expenses (13,900)   (17,515)
Increase (decrease) in accounts payable and accrued liabilities (41,475) 19,596 1,330,249
Increase in advances payable 5,000 52,182 3,151,985
Increase in interest payable 126,391 154,182 3,903,270
Net cash used in operating activities (371,362) (157,474) (12,383,966)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Net cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Other financing activities     (115,472)
Expenditures to repurchase shares     (342,038)
Proceeds from issuance of shares     1,512,402
Repayment of promissory notes payable     (970,879)
Proceeds from borrowings on line of credit 366,131 164,303 12,348,802
Net cash provided by financing activities 366,131 164,303 12,432,815
Net increase (decrease) in cash (5,231) 6,829 5,771
Cash, beginning of period 11,002 1,829  
Cash, end of period 5,771 8,658 5,771
Shares issued to settle liabilities     6,807,473
Cash paid for interest   5,857 1,223,335
Interest expense incurred in connection with options granted in exchange for increase in borrowing limit on existing line of credit financing   1,493,702 1,493,702
Interest expense incurred in connection with options granted as compensation for receiving line of credit financing $ 231,948   $ 6,480,723